Upcoming catalysts and material SEC filings for Immuneering Corp (IMRX). 2 upcoming catalysts.
Trial readout (estimated)
October 2027 · Estimated — subject to change
Trial readout (estimated)
June 2028 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 2d ago